Phytopharm hit by failure of Parkinson's drug
LONDON (Reuters) - Phytopharm said its major drug hope for treating Parkinson's disease had failed in a clinical trial, the latest British biotech company to disappoint after showing early promise. Shares in Phytopharm fell more than 80 percent on Monday after it said its drug, Cogane, showed no benefit over placebo in the treatment of more than 400 patients with early-stage Parkinson's, a neurodegenerative disease. Chief Executive Tim Sharpington said he was disappointed. ...
Source: news.yahoo.com
No comments:
Post a Comment